Please assess the completion status of the following clinical trial:

Trial Title: Systems Biology of Gastrointestinal and Related Diseases

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria~* Any patient 18 years old or older that schedules a visit to WAGI clinics or endoscopy center~* Able to use electronic communications~* Able to communicate in English~* Consent to participate in the study~Exclusion Criteria:~* None

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ulcerative Colitis (Type: None): Participants with ulcerative colitis.
- Crohn's Disease (Type: None): Participants with Crohn's disease.
- Obesity (Type: None): Participants that are obese.
- Colon Polyps (Type: None): Participants with colon polyps.
- Eosinophilic esophagitis (Type: None): Participants with Eosinophilic esophagitis
- Gastroesophageal Reflux Disease (GERD) (Type: None): Participants with Gastroesophageal Reflux Disease (GERD).
- Gastritis (Type: None): Participants with gastritis.
- Gastric ulcers (Type: None): Participants with gastric ulcers.
- Duodenal ulcers (Type: None): Participants with duodenal ulcers.
- Intestinal metaplasia (Type: None): Participants with intestinal metaplasia (risk factor for esophageal cancer).
- Gastric Cancer (Type: None): Participants with gastric cancer.
- Lymphocytic/Microscopic Colitis (Type: None): Participants with Lymphocytic/Microscopic Colitis.
- Celiac Sprue (Type: None): Participants with Celiac Sprue.
- Irritable Bowel Syndrome (IBS) (Type: None): Participants with IBS.
- Small intestinal bacterial overgrowth (SIBO) (Type: None): Participants with SIBO.
- Non-alcoholic Fatty Liver Disease (NAFLD) (Type: None): Participants with NAFLD.
- Gallstone disease (Type: None): Participants with Gallstone disease.

Based on this trial design, predict the completion outcome and termination type (if applicable).